Results 11 to 20 of about 8,998 (169)

Primary hyperaldosteronism [PDF]

open access: yesAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2003
Primary hyperaldosteronism is an important cause of hypertension. Its true prevalence is still a matter of debate, since about 10% of hypertensives may have underlying hyperaldosteronism. Primary hyperaldosteronism is due to aldosterone-secreting tumours, bilateral adrenal hyperplasia or, rarely, adrenal carcinoma or genetic causes ...
Sunil, Nadar   +2 more
openaire   +5 more sources

Genetics of primary hyperaldosteronism [PDF]

open access: yesEndocrine-Related Cancer, 2016
Hypertension is a common medical condition and affects approximately 20% of the population in developed countries. Primary aldosteronism is the most common form of secondary hypertension and affects 8–13% of patients with hypertension. The two most common causes of primary aldosteronism are aldosterone-producing adenoma and bilateral adrenal ...
Ravi Kumar, Dutta   +2 more
openaire   +2 more sources

Primary Hyperaldosteronism As A Risk Factor For Recurrent Nephrolithiasis

open access: yesKidney Research and Clinical Practice, 2012
Primary hyperaldosteronism typically presents as hypertension, hypokalemia, and metabolic alkalosis. Several previous reports note an association between primary hyperaldosteronism and nephrolithiasis with secondary hyperparathyroidism.
Ekamol Tantisattamo, Thomas B. Francis
doaj   +1 more source

Primary hyperaldosteronism with concomitant cortisol secretion [PDF]

open access: yesНаука и инновации в медицине
Aim – to study the diagnostic possibilities of comparative selective venous blood sampling from the central adrenal vein in patients with primary hyperaldosteronism with combined autonomous cortisol secretion. Material and methods.
Aleksandr A. Lisitsyn   +5 more
doaj   +1 more source

Primary hyperaldosteronism: diagnosis and treatment

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2017
The aspects of primary hyperaldosteronism that have an important social and medical value are examined in this lecture. It is underlined that in some patients with timely diagnosis and choice of optimal therapeutic approach, a complete recovery is ...
L.A. Nikitiuk   +3 more
doaj   +1 more source

Coexistence of Primary Hyperaldosteronism and Graves’ Disease, a Rare Combination of Endocrine Disorders: Is It beyond a Coincidence—A Case Report and Review of the Literature

open access: yesCase Reports in Endocrinology, 2017
Background. Primary hyperaldosteronism is a known cause for secondary hypertension. In addition to its effect on blood pressure, aldosterone exhibits proinflammatory actions and plays a role in immunomodulation/development of autoimmunity.
S. S. C. Gunatilake, U. Bulugahapitiya
doaj   +1 more source

The problem of timely diagnosis of primary hyperaldosteronism. Clinical case

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2023
A clinical case is presented of delayed diagnosis of primary hyperaldosteronism (PHA) due to aldosterone-producing adenoma. Suspicion of PHA arises in case of persistent combination of hypertension with hypokalemia of various severity, a specific ...
V.M. Zhdan   +6 more
doaj   +1 more source

Spectrum of Clinical and Pathogenetic Forms of Primary Hyperaldosteronism

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2015
The aim of the study was to investigate the spectrum of different pathogenetic forms of primary hyperaldosteronism on the clinical data of Ukrainian Scientific and Practical Center of Endocrine Surgery, Endocrine Organs and Tissues Transplantation within
L.V. Shchekaturova
doaj   +1 more source

Primary hyperaldosteronism presenting as hypokalaemic periodic paralysis

open access: yesSri Lanka Journal of Diabetes Endocrinology and Metabolism, 2019
Hypokalaemic periodic paralysis is episodic painless muscle weakness associated with areflexia (1). Hypertension and hypokalaema are the classic presentation of primary hyperaldoteronism though some patients can be normokalaemic (2).
A. S. Embuldeniya   +3 more
doaj   +1 more source

Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy

open access: yesРациональная фармакотерапия в кардиологии, 2023
The literature review is devoted to modern ideas about the role of hyperaldosteronism as one of the important pathophysiological links in hypertension (HTN) development.
S. R. Gilyarevsky, D. O. Ladygina
doaj   +1 more source

Home - About - Disclaimer - Privacy